Transform Wealth, LLC Kazia Therapeutics LTD Transaction History

Transform Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 26, 2022	SELL	$7.35 - $12.0 $780,900 - $1.27 Million	-106,245 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$8.65 - $11.64 $919,019 - $1.24 Million	106,245 New	106,245 $120,000
Q3 2021 Oct 15, 2021	SELL	$8.65 - $11.64 $919,019 - $1.24 Million	-106,245 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$3.05 - $3.9 $324,047 - $414,355	106,245 New	106,245 $32,000

44.6K

Ticker KZIA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,111,300
Market Cap $13.6M
Description
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...

Get notified when there are updates to the investment portfolio of Transform Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Transform Wealth, LLC with notifications on news.